CurveBeam AI Limited (ASX:CVB)

Market Cap	27.32M
Revenue (ttm)	7.91M
Net Income (ttm)	-19.45M
Shares Out	390.27M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,459
Average Volume	109,762
Open	0.0710
Previous Close	0.0710
Day's Range	0.0710 - 0.0710
52-Week Range	0.0650 - 0.2900
Beta	n/a
RSI	43.57
Earnings Date	Aug 29, 2025

About CurveBeam AI

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe and North America. The company builds artificial intelligence tools to aid in bone separation and segmentation, empowering orthopedic surgeons to make 3D-based deformity measurements to inform clinical decisions. It is also involved in AI’s Deep Learning AI based platform aids in bone microstructure analysis. The company’s target customers include orthopedic practices, imaging centers, and hospitals. Cu...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 50
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CVB

Financial Performance

In 2024, CurveBeam AI's revenue was 6.53 million, a decrease of -18.97% compared to the previous year's 8.06 million. Losses were -23.10 million, -54.90% less than in 2023.